an Observational Study Evaluting the Effectiveness and Safety of DKutting LL Noval Scoring Balloon Angioplasty for Vessel Preparation Facilitated by IVUS on the Lower Limb Ischemia Patients With Calcified Lesions
A legfontosabb adatok
- Ki végzi
- The First Affiliated Hospital of Dalian Medical University
- Hol
- Dalian (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Csak meghívásos
- Résztvevők
- 58 fő, tervezett
- Kezdés
- 2026. márc. 17.
- Várható befejezés
- 2027. márc. 30.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- DKutting LL scoring balloon angioplasty
- A regiszteradat frissítve
- 2026. április 3.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with narrowed or blocked leg arteries that have moderate to severe calcium build-up. They will be treated with the DKutting LL scoring balloon, guided by IVUS (an ultrasound camera inside the artery).
- Életkor
- 18 to 85 years
- Nem
- All sexes
- A betegség stádiuma
- Hardened leg arteries (atherosclerotic disease) with Rutherford Category 2-5. The narrowing is in the femoropopliteal or infrapopliteal arteries. It is ≥70% or a full long-term blockage (CTO). Calcium is moderate to severe (PACSS Grade 3-4). Total length is ≤150 mm. The vessel diameter is ≥2 mm. Life expectancy is > 1 year.
- Korábbi kezelés
- The narrowing can be new or can have come back after earlier balloon treatment (PTA). No stent within 2 cm (0,8 in) of the target lesion. People with a previous stent or bypass surgery in the target vessel cannot join.
A részvétel fő kizáró okai
- Allergy to contrast dye, bleeding disorders, severe liver problems or severe heart failure (NYHA Class III-IV)
- Heart attack or stroke in the past 3 months, or blood thinners not possible
- Sudden limb ischemia (loss of blood flow), clots in the lesion, or an aneurysm in the same leg
- Planned amputation, being bedridden or unable to walk, or deep foot wounds (WIfI Stage 3)
- Pregnant or breastfeeding women
A regiszter feltételei, szó szerint
Mind a 28 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥ 18 years and ≤ 85 years
- Clinical diagnosis of lower extremity atherosclerotic arterial disease, with a Rutherford Classification of Category 2-5
- The patient has provided written informed consent
- Life expectancy > 1 year
- Confirmed by clinical and CTA examination: de novo or restenotic lesions after PTA in the femoropopliteal or infrapopliteal arteries, with no stent implantation within 2 cm of the target lesion. Stenosis ≥70% or chronic total occlusion (CTO)
- Lesion confirmed by CTA and color Doppler to have moderate to severe calcification (PACSS Grade 3-4). Lesion can be single or tandem, with a total length ≤150 mm. Reference vessel diameter near the target lesion ≥2 mm
- Allowable location of the target lesion: ≥1 cm distal to the common femoral artery bifurcation, and up to 10 cm above the ankle
- If the lesion is below-the-knee (BTK), the inflow vessels must have no non-target lesions, or any non-target lesions must be successfully treated with the current device without vascular complications
- No serious vascular complications such as flow-limiting dissection occur after pre-dilation of the target lesion
- Presence of at least one reconstructible infrapopliteal runoff vessel patent to the ankle
Ki nem vehet részt
- Previous stent implantation or bypass surgery in the target vessel
- Contraindications to anticoagulation or antiplatelet therapy
- Intraoperative occurrence of severe complications requiring conversion to other treatment methods (e.g., bypass surgery)
- Planned use of adjunctive therapy devices (e.g., atherectomy, laser)
- Participation in another interventional drug/device clinical study for lower limb arteries where the primary endpoint has not been reached, or planned participation in such a study
- Allergy to contrast media
- Cardiac insufficiency (New York Heart Association Class III-IV)
- Acute cardiovascular events (e.g., acute myocardial infarction, stroke) within the past 3 months; active gastrointestinal bleeding affecting the use of anticoagulant/antiplatelet therapy
- Failure to cross the lesion with a guidewire during the procedure; anticipation that the IVUS catheter or DKutting balloon will be unable to cross the lesion after pre-dilation
- Active infection at the intended treatment site; foot wounds reaching WIfI Stage 3, or ankle/foot ulcers primarily of non-ischemic etiology
- Coagulopathy; severe hepatic insufficiency (ALT or AST > 3 times the upper limit of normal)
- Life expectancy < 1 year
- Acute/subacute limb ischemia or thrombotic lesions
- Pregnant or lactating women
- Patient withdrawal of informed consent
- Planned amputation
- Patient is bedridden or unable to walk
- Presence of an aneurysm in the ipsilateral limb vasculature
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 85 év között vagy?
Helyszínek itt: Kína
- The First Affiliated Hospital of Dalian Medical UniversityDalian, KínaCsak meghívásos
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is a prospective, single-center, single-arm, observational study. It plans to enroll 58 patients with moderate to severely calcified lesions in the femoropopliteal or infrapopliteal arteries. Participants will be treated with the Scoring Balloon Dilatation Catheter manufactured by DK Medtech (Suzhou) Co., Ltd. The study aims to evaluate the immediate technical success rate and the improvement in lumen area and calcification burden as assessed by IVUS following percutaneous transluminal angioplasty with the scoring balloon. Clinical follow-ups will be conducted at discharge (or within 7 days), 1 month, 3 months, and 6 months post-procedure to observe secondary endpoints including the incidence of clinically driven target lesion revascularization and changes in Rutherford classification
A vizsgálat csoportja
- Dkutting LL treatment group
IVUS facilitated DKutting LL angioplasty
Kezelés: DKutting LL scoring balloon angioplasty
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Prospective, Single-Arm Observational Study on the Effectiveness and Safety of the DKutting® LL Balloon in VEssel Preparation for CALcified Lesions in Infra-inguinal Arteries, the DkuLL CALVEP Study.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07397390: ki vehet részt
- A regiszteradat frissítve
- 2026. április 3.